Indaziflam Patent Landscape Analysis

Indaziflam is a Group 29 herbicide developed by Bayer, commercialised through the Alion® brand.

The retained landscape covers 66 patent families across 22 consolidated owner groups. Herbicide combination is the thickest protection layer (31 families), with manufacturing route and formulation claims providing additional constraint.

46 of the 66 retained families carry a grant or national pending reading. 18 families are held by China-based applicants. 3 live families have a nominal term ending within five years. Position as at November 2026.

This 44-page report provides a seven-part analysis covering ownership, active-ingredient manufacture, single-active formulation, fixed-dose mixtures, national market entry and owner profiles, with route-level remaining-space notes and an appendix owner directory.

Not a freedom-to-operate opinion.